Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tong Ren Tang Technologies Co ( (HK:1666) ) has issued an announcement.
Tong Ren Tang Technologies Co. Ltd. announced the interim financial results of its subsidiary, Tong Ren Tang Chinese Medicine, for the first half of 2025. The subsidiary reported a revenue increase to HK$761,736,000, up from HK$664,518,000 in the same period in 2024, with a profit for the period of HK$245,936,000. This financial performance highlights the company’s strong market position and potential growth in the traditional Chinese medicine sector.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. Ltd. operates in the traditional Chinese medicine industry, focusing on the production and distribution of Chinese medicinal products. The company is known for its extensive range of herbal medicines and health products, catering to both domestic and international markets.
Average Trading Volume: 1,501,746
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.89B
For an in-depth examination of 1666 stock, go to TipRanks’ Overview page.